| Hydroxychloroquine dose per ophthalmology guidelines and the risk of systemic lupus erythematosus flares AM Jorge, C Mancini, B Zhou, G Ho, Y Zhang, K Costenbader, HK Choi JAMA 328 (14), 1458-1460, 2022 | 34 | 2022 |
| Hydroxychloroquine dose and risk for incident retinopathy: a cohort study RB Melles, AM Jorge, MF Marmor, B Zhou, C Conell, J Niu, N McCormick, ... Annals of internal medicine 176 (2), 166-173, 2023 | 20 | 2023 |
| Periodontal and other oral bacteria and risk of lung cancer in the Atherosclerosis Risk in Communities (ARIC) Study B Zhou, J Lu, JD Beck, KL Moss, AE Prizment, RT Demmer, ... Cancer Epidemiology, Biomarkers & Prevention 32 (4), 505-515, 2023 | 7 | 2023 |
| Comparative risks of infection with belimumab versus Oral immunosuppressants in patients with nonrenal systemic lupus erythematosus E Materne, H Choi, B Zhou, KH Costenbader, Y Zhang, A Jorge Arthritis & Rheumatology 75 (11), 1994-2002, 2023 | 5 | 2023 |
| Response to SARS-CoV-2 initial series and additional dose vaccine in pediatric patients with predominantly antibody deficiency M Tandon, DV DiGiacomo, B Zhou, P Hesterberg, CE Rosenberg, ... Frontiers in Immunology 14, 1217718, 2023 | 3 | 2023 |
| 621 Risk of damage progression with belimumab versus oral immunosuppressant use in patients with systemic lupus erythematosus A Jorge, B Zhou, Y Zhang, H Choi Lupus Science & Medicine 11 (Suppl 2), 2024 | 1 | 2024 |
| Risk Factors for Hydroxychloroquine Retinopathy and Its Subtypes AM Jorge, RB Melles, MF Marmor, B Zhou, Y Zhang, HK Choi JAMA Network Open 7 (5), e2410677-e2410677, 2024 | 1 | 2024 |
| Hypogammaglobulinemia and Risk of Infectious Complications in Patients Receiving Idecabtagene vicleucel S Barmettler, J Little, B Zhou, M Tandon, M Frigault, N Raje, N Munshi, ... Journal of Allergy and Clinical Immunology 151 (2), AB224, 2023 | 1 | 2023 |
| Hydroxychloroquine Dose and Hospitalizations for Active Lupus J Nestor, H Choi, C Mancini, B Zhou, Y Zhang, KH Costenbader, A Jorge Arthritis & Rheumatology, 2024 | | 2024 |
| POS0939 SERUM URATE CHANGE AMONG GOUT PATIENTS TREATED WITH SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS VS. SULFONYLUREA: A COMPARATIVE EFFECTIVENESS ANALYSIS C Yokose, G Challener, B Jiang, B Zhou, N Mccormick, S Tanikella, ... Annals of the Rheumatic Diseases 83 (Suppl 1), 571-572, 2024 | | 2024 |
| Serum urate change among gout patients treated with sodium-glucose cotransporter type 2 inhibitors vs. sulfonylurea: A comparative effectiveness analysis C Yokose, G Challener, B Jiang, B Zhou, N McCormick, S Tanikella, ... Seminars in Arthritis and Rheumatism 66, 152441, 2024 | | 2024 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency AM Zhang, A Elmoursi, DV DiGiacomo, B Zhou, M Tandon, JS Hong, ... Journal of Allergy and Clinical Immunology: Global 3 (2), 100234, 2024 | | 2024 |
| Renal complications in patients with predominantly antibody deficiency in the United States Immune Deficiency Network (USIDNET) E Materne, B Zhou, D DiGiacomo, JR Farmer, R Fuleihan, KE Sullivan, ... Journal of Allergy and Clinical Immunology, 2024 | | 2024 |
| Hypogammaglobulinemia and Risk of Infection Following Daratumumab in Patients with Multiple Myeloma J Hong, B Zhou, A Pak, N Yang, S Barmettler Journal of Allergy and Clinical Immunology 153 (2), AB231, 2024 | | 2024 |
| Hypogammaglobulinemia Following Use of An Anti-neonatal Fc Receptor (FcRn) Monoclonal Antibody, Efgartigimod. N Yang, B Zhou, J Hong, S Barmettler Journal of Allergy and Clinical Immunology 153 (2), AB28, 2024 | | 2024 |
| Association of CD19+-Targeted Chimeric Antigen Receptor (CAR) T-cell Therapy with Hypogammaglobulinemia and Infection N Sutherland, B Zhou, J Walter, C Camargo, S Barmettler Journal of Allergy and Clinical Immunology 153 (2), AB231, 2024 | | 2024 |
| Immunophenotypic Risk Factors for Low SARS-CoV-2 Immunization Response in Adults with Predominantly Antibody Deficiency over Five Total Vaccine Doses A Zhang, A ELMOURSI, D Digiacomo, B Zhou, M Tandon, J Hong, ... Journal of Allergy and Clinical Immunology 153 (2), AB244, 2024 | | 2024 |
| SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD) A ELMOURSI, A Zhang, D Digiacomo, B Zhou, M Tandon, J Hong, ... Journal of Allergy and Clinical Immunology 153 (2), AB245, 2024 | | 2024 |
| Infections and Hypogammaglobulinemia in Thymoma Patients: The Importance of Immunological Monitoring to Identify Good's Syndrome A Pak, B Zhou, J Hong, S Barmettler Journal of Allergy and Clinical Immunology 153 (2), AB230, 2024 | | 2024 |
| An imperfect world: Assessing safety of biological treatments in SLE-In Reply. AM Jorge, E Materne, B Zhou, K Costenbader, Y Zhang, HK Choi Arthritis & Rheumatology (Hoboken, NJ), 2023 | | 2023 |
